Lean Entries

Lean Entries represents a legitimate B2B HealthTech solution acquired by Labquality in 2021, addressing a high-utility niche in medical device regulation (MDR/IVDR). However, the project submission itself is of critically low quality, containing hyperbolic and demonstrably false claims (e.g., audience is 'everyone', traction is 'most people'). While the underlying project has real-world merit and verifiable success via acquisition, the Proof of Usefulness score is heavily penalized by the lack of credible data input and the disconnect between the niche reality and the submission's mass-market claims.